SecBot SecBot
SECBOTREPLAY Home › Report › MEDS

MEDS · ATM facility up to $10M

DataMeds AI, Inc. · 8-K filed Nov 16, 2026 at 06:01 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Nov 16, 2026 at 06:01 ET

DataMEDS AI, Inc. entered into an ATM sales agreement with Dawson James Securities to sell up to $10,003,649 of its common stock from time to time in at-the-market offerings. The company is not obligated to sell any shares, and the agreement provides a 3.0% commission to the sales agent. This establishes a potential equity dilution facility but no shares have been sold yet.

  • DataMEDS AI, Inc. entered into an ATM sales agreement with Dawson James Securities on November 16, 2026
  • Maximum offering amount is $10,003,649 of common stock
  • Sales agent receives 3.0% commission on gross proceeds from each sale
  • Company is not obligated to sell any shares under the agreement

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access